back

Standard Operating Procedures for Clinical Trials

SOP	Title

General Administration (GA)
GA-101.02	SOP on SOPs: Preparing, Maintaining and Training
GA-102.02	Sponsor Responsibility and Delegation of Responsibility
GA-103.02	Training and Education
GA-104.01	Document Development and Change Control

Study Start-Up (SS)
SS-201.04	Assessing Protocol Feasibility
SS-202.01	Investigator Selection
SS-203.02	Pre-Study Site Visit (PSSV)

Study Management (SM)
SM-301.01	Communication
SM-303.02	Documentation and Records Retention
SM-304.01	Routine Monitoring Visits
SM-305.01	Closeout Visits
SM-306.01	Adverse Event Reporting
SM-307.01	Investigational Product Management
SM-308.02	Specimen Management

Data Management (DM)
DM-401.01	Data Management

Privacy Practices (PP)
PP-501.01	Safeguarding Protected Health Information

Quality Assurance (QA)
QA-601.02	FDA or Pharmaceutical Sponsored Audits

Last Updated: 2/18/2021 2:46:25 PM

Clinical Trials, Doctors & Cancer Centers

Georgia Cancer Trial Finders Provider Engagement Webinar

Join us for a 35-minute Georgia Cancer Trial Finders Provider Engagement Webinar on March 26 from 12:15–12:50 PM (ET) featuring Dr. Trevor Feinstein, Chief Medical Officer of Georgia CORE, and Dr. Crain Garrott, Past President of the Georgia Society of Clinical Oncology (GASCO).

Because many referrals to Georgia Cancer Trial Finders originate from clinical teams, increasing provider awareness of this res

3/13/2026

Clinical Trials, Doctors & Cancer Centers